Performance of male C57BL/6J mice and Wistar rats in the water maze following various schedules of phencyclidine treatment.
In order to establish an animal model of cognitive impairments relevant to schizophrenia, we set out to obtain an optimal treatment protocol with phencyclidine (PCP) that would lead to robust cognitive impairment with minimal PCP-related adverse effects. Effects of various doses (0.63-5 mg/kg), pre-treatment period (0, 3, 7 and 10 days before the beginning of acquisition) and treatment schedules (before the first or immediately after the last trial on each day) of PCP on the performance of male C57BL/6J mice and Wistar rats in the spatial version of the water maze were studied. In mice, a 10-day pre-treatment period was required to prevent PCP-induced motor impairments, whereas a 3-day pre-treatment was sufficient in rats. PCP impaired spatial learning in both rats and mice, if animals were administered PCP prior to the first trial. The optimal dose was 2.5 mg/kg. In contrast, animals given PCP immediately after the daily training sessions performed as well as controls. Thus, PCP impairs spatial learning in the water maze only when present in the organism. It can be concluded that PCP interferes with learning, and perhaps retrieval, but not consolidation of newly acquired information.
Podhorna
J
J
Department of Psychopharmacology - Psychosis, H. Lundbeck A/S, Ottiliavej 9, 2500 Copenhagen - Valby, Denmark.
Didriksen
M
M
D000818:Animals; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D006213:Hallucinogens / Q000009:adverse effects / Q000494:pharmacology*; D018782:Maze Learning / Q000187:drug effects*; D051379:Mice; D008810:Mice, Inbred C57BL; D010622:Phencyclidine / Q000009:adverse effects / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar; D013045:Species Specificity
D006213:Hallucinogens; D010622:Phencyclidine